{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:24:01Z","timestamp":1787095441069,"version":"build-2736575974"},"reference-count":134,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acquired von Willebrand syndrome (AVWS) is a rare condition characterized by an acquired functional and\/or absolute deficiency of the von Willebrand factor (VWF) protein. The absence of widely accepted diagnostic criteria has hampered accurate estimates of incidence and prevalence, which are largely currently unknown. As bleeding symptoms are not included in the most widely used definitions, AVWS should be managed as a risk factor for bleeding, rather than a specific disease entity. The diagnostic workup is cumbersome, involving measurement of both VWF antigen, VWF glycoprotein Ib binding activity, VWF collagen binding activity, and, preferentially, also VWF multimer analyses. Moreover, since the presence of bleeding symptoms is not required for diagnosis, the condition is probably underdiagnosed. In contrast to acquired hemophilia, AVWS is seldom caused by the presence of specific antibodies, but rather secondary to another disorder, most commonly lymphoproliferative, myeloproliferative, cardiovascular, and autoimmune disorders. Pathogenesis of AVWS varies according to the underlying disorder and includes nonspecific adsorption of VWF to antibodies, adsorption onto surfaces of neoplastic cells, mechanical injury, or VWF proteolysis. Treatment includes treating the underlying cause as well as stopping acute bleeds. Here, we present a comprehensive review of what is currently known regarding demographics, diagnostics, and clinical presentation of the syndrome. Since no prospective treatment studies have been performed, treatment choices must be based on data from registries and case reports that are also summarized. Moreover, we present treatment experiences of previously unpublished Nordic cases.<\/jats:p>","DOI":"10.1055\/a-2765-9556","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T23:41:23Z","timestamp":1766446883000},"page":"628-644","source":"Crossref","is-referenced-by-count":1,"title":["Acquired von Willebrand Syndrome: A Comprehensive Review and a Nordic Perspective"],"prefix":"10.1055","volume":"52","author":[{"given":"Eva","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Coagulation Unit, Department of Hematology, Oncology and Radiation Physics, Sk\u00e5ne University Hospital, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Strandberg","sequence":"additional","affiliation":[{"name":"Division of Laboratory Medicine, Coagulation Laboratory, Department of Clinical Chemistry and Pharmacology, University and Regional Laboratories Region Sk\u00e5ne, Malm\u00f6, Sweden"},{"name":"Department of Translational Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hillarp","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Lund University, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuokko","family":"Nummi","sequence":"additional","affiliation":[{"name":"Coagulation Disorders Unit, Department of Haematology, Helsinki University Hospital Comprehensive Cancer Centre and Helsinki University, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timea","family":"Szanto","sequence":"additional","affiliation":[{"name":"Coagulation Disorders Unit, Department of Haematology, Helsinki University Hospital Comprehensive Cancer Centre and Helsinki University, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Elina","family":"Lehtinen","sequence":"additional","affiliation":[{"name":"Coagulation Disorders Unit, Department of Haematology, Helsinki University Hospital Comprehensive Cancer Centre and Helsinki University, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-2505","authenticated-orcid":false,"given":"Anne Louise","family":"T\u00f6llb\u00f6ll S\u00f6rensen","sequence":"additional","affiliation":[{"name":"Department of Haematology, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Olsson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Vaide","sequence":"additional","affiliation":[{"name":"Department of Haematology and Oncology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Funding","sequence":"additional","affiliation":[{"name":"Department of Haematology, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V31.6.806.806","article-title":"Acquired von Willebrand's syndrome in systemic lupus erythematosus","volume":"31","author":"J V Simone","year":"1968","journal-title":"Blood"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.0954-6820.1978.tb08484.x","article-title":"Acquired von Willebrand's disease caused by a monoclonal antibody","volume":"204","author":"O Zettervall","year":"1978","journal-title":"Acta Med Scand"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3109\/10428194.2013.827788","article-title":"Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyurea","volume":"55","author":"E Verner","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.17219\/acem\/64942","article-title":"Acquired von Willebrand Syndrome","volume":"25","author":"A Mital","year":"2016","journal-title":"Adv Clin Exp Med"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"N T Connell","year":"2021","journal-title":"Blood Adv"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11239-018-1663-9","article-title":"The course of acquired von Willebrand syndrome during pregnancy among patients with essential thrombocytosis","volume":"46","author":"A Rottenstreich","year":"2018","journal-title":"J Thromb Thrombolysis"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hon.2903","article-title":"Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis","volume":"39","author":"C Trotti","year":"2021","journal-title":"Hematol Oncol"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5045\/br.2023.2022218","article-title":"Acquired von Willebrand syndrome in patients with Philadelphia-negative myeloproliferative neoplasm","volume":"58","author":"I C Song","year":"2023","journal-title":"Blood Res"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5551\/jat.RV17031","article-title":"Acquired von Willebrand syndrome associated with cardiovascular diseases","volume":"26","author":"H Horiuchi","year":"2019","journal-title":"J Atheroscler Thromb"},{"issue":"02","key":"ref10","first-page":"345","article-title":"Acquired von Willebrand syndrome: data from an international registry","volume":"84","author":"A B Federici","year":"2000","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1538-7836.2008.02917.x","article-title":"Acquired von Willebrand syndrome: is it an extremely rare disorder or do we see only the tip of the iceberg?","volume":"6","author":"A B Federici","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"S 02","key":"ref12","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0049-3848(13)70003-3","article-title":"Diagnosis and treatment of acquired von Willebrand syndrome","volume":"130","author":"A Tiede","year":"2012","journal-title":"Thromb Res"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-0609.2011.01636.x","article-title":"Pathophysiology of acquired von Willebrand disease: a concise review","volume":"87","author":"S Shetty","year":"2011","journal-title":"Eur J Haematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2147\/JBM.S266791","article-title":"Why is misdiagnosis of von Willebrand disease still prevalent and how can we overcome it? A focus on clinical considerations and recommendations","volume":"12","author":"C K Colonne","year":"2021","journal-title":"J Blood Med"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/rth2.12150","article-title":"Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome","volume":"2","author":"S Deconinck","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/107602960100700206","article-title":"Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine","volume":"7","author":"J J Michiels","year":"2001","journal-title":"Clin Appl Thromb Hemost"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/hae.12275","article-title":"Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study","volume":"20","author":"D J Stuijver","year":"2014","journal-title":"Haemophilia"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0033-1334867","article-title":"Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update","volume":"39","author":"A B Federici","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0038-1660481","article-title":"Evaluation of the utility of von Willebrand factor propeptide in the differential diagnosis of von Willebrand disease and acquired von Willebrand syndrome","volume":"45","author":"F Stufano","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"ref21","first-page":"87","article-title":"Measurement of factor VIII inhibitors","volume":"150","author":"C K Kasper","year":"1984","journal-title":"Prog Clin Biol Res"},{"issue":"102","key":"ref22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2516.2008.01924.x","article-title":"Diagnosis and quantification of factor VIII inhibitors","volume":"16","author":"B Verbruggen","year":"2010","journal-title":"Haemophilia"},{"key":"ref23","first-page":"109","article-title":"Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease","volume":"150","author":"P M Mannucci","year":"1984","journal-title":"Prog Clin Biol Res"},{"issue":"03","key":"ref24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2516.2003.00750.x","article-title":"A new ELISA assay for diagnosis of acquired von Willebrand syndrome","volume":"9","author":"C Siaka","year":"2003","journal-title":"Haemophilia"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jtha.2023.01.001","article-title":"von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS","volume":"21","author":"M T Pagliari","year":"2023","journal-title":"J Thromb Haemost"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/978-1-0716-3175-1_45","article-title":"Laboratory testing for von Willebrand factor: factor VIII binding for the diagnosis or exclusion of type 2N von Willebrand disease: an update","volume":"2663","author":"E J Favaloro","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/beha.2001.0141","article-title":"Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management","volume":"14","author":"J J Michiels","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"08","key":"ref28","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ajh.20455","article-title":"Acquired von Willebrand syndrome: features and management","volume":"81","author":"H Mohri","year":"2006","journal-title":"Am J Hematol"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1213\/ANE.0b013e318236b16a","article-title":"Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease","volume":"114","author":"S Lison","year":"2012","journal-title":"Anesth Analg"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1538-7836.2008.02909.x","article-title":"Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study","volume":"6","author":"A Tiede","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref31","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/bjh.15200","article-title":"Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenstr\u00f6m macroglobulinaemia","volume":"184","author":"J J Castillo","year":"2019","journal-title":"Br J Haematol"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1055\/a-1896-7092","article-title":"Bleeding propensity in Waldenstr\u00f6m macroglobulinemia: potential causes and evaluation","volume":"122","author":"S A Brysland","year":"2022","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/rth2.12481","article-title":"Acquired von Willebrand syndrome in monoclonal gammopathy - a scoping review on hemostatic management","volume":"5","author":"M Y Abou-Ismail","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ejh.13331","article-title":"Disease progression and defects in primary hemostasis as major cause of bleeding in multiple myeloma","volume":"104","author":"C Hinterleitner","year":"2020","journal-title":"Eur J Haematol"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ajh.20830","article-title":"Acquired von Willebrand syndrome: an update","volume":"82","author":"M Franchini","year":"2007","journal-title":"Am J Hematol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1053\/j.seminhematol.2005.11.003","article-title":"Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders","volume":"43","author":"A B Federici","year":"2006","journal-title":"Semin Hematol"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.20829","article-title":"Association of acquired von Willebrand syndrome with AL amyloidosis","volume":"82","author":"C A Kos","year":"2007","journal-title":"Am J Hematol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2016.11.011","article-title":"Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera","volume":"41","author":"A Rottenstreich","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"914","DOI":"10.20452\/pamw.3211","article-title":"Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients","volume":"125","author":"A Mital","year":"2015","journal-title":"Pol Arch Intern Med"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.thromres.2015.07.029","article-title":"Factors predisposing to acquired von Willebrand syndrome during the course of polycythemia vera - retrospective analysis of 142 consecutive cases","volume":"136","author":"A Mital","year":"2015","journal-title":"Thromb Res"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.17219\/acem\/52361","article-title":"Acquired von Willebrand syndrome during the course of myelofibrosis: analysis of 32 cases","volume":"24","author":"A Mital","year":"2015","journal-title":"Adv Clin Exp Med"},{"issue":"25","key":"ref42","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"A Tiede","year":"2011","journal-title":"Blood"},{"issue":"03","key":"ref43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/107602969900500301","article-title":"Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia","volume":"5","author":"J J Michiels","year":"1999","journal-title":"Clin Appl Thromb Hemost"},{"issue":"22","key":"ref44","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood.2019001318","article-title":"From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms","volume":"134","author":"B L Stein","year":"2019","journal-title":"Blood"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/bjh.16241","article-title":"Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukaemia in children","volume":"188","author":"R Kn\u00f6fler","year":"2020","journal-title":"Br J Haematol"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1200\/JCO.1992.10.3.422","article-title":"Acquired von Willebrand disease in Wilms' tumor patients","volume":"10","author":"M J Coppes","year":"1992","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1096-911X(199604)26:4<238::AID-MPO3>3.0.CO;2-K","article-title":"Acquired Von Willebrand disease in children with a Wilms' tumor","volume":"26","author":"A B Jonge Poerink-Stockschlader","year":"1996","journal-title":"Med Pediatr Oncol"},{"issue":"04","key":"ref48","first-page":"253","article-title":"Wilms' tumour with acquired von Willebrand's disease","volume":"23","author":"P Han","year":"1987","journal-title":"Aust Paediatr J"},{"issue":"03","key":"ref49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajh.2830240304","article-title":"Platelet dysfunction associated with Wilms tumor and hyaluronic acid","volume":"24","author":"A W Bracey","year":"1987","journal-title":"Am J Hematol"},{"issue":"06","key":"ref50","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3476(79)80293-0","article-title":"Acquired von Willebrand disease in a patient with Wilms tumor","volume":"95","author":"P A Noronha","year":"1979","journal-title":"J Pediatr"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1182\/blood.V58.4.665.665","article-title":"Acquired von Willebrand's disease in association with Wilm's tumor: regression following treatment","volume":"58","author":"J P Scott","year":"1981","journal-title":"Blood"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1017\/S0022215100128944","article-title":"Epistaxis, von Willebrand's type bleeding diathesis and Wilms' tumour: a case report","volume":"108","author":"P V Lim","year":"1994","journal-title":"J Laryngol Otol"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00383-002-0853-9","article-title":"Coagulopathy associated with Wilms' tumour: a rare complication","volume":"19","author":"S Singh","year":"2003","journal-title":"Pediatr Surg Int"},{"issue":"07","key":"ref54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00431-004-1443-8","article-title":"Coagulopathy as a presenting feature of Wilms tumour","volume":"163","author":"R S Leung","year":"2004","journal-title":"Eur J Pediatr"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2516.2006.01218.x","article-title":"Paediatric acquired von Willebrand syndrome","volume":"12","author":"A Will","year":"2006","journal-title":"Haemophilia"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mpo.2950250213","article-title":"Acquired von Willebrand disease in malignant peripheral neuroectodermal tumor (PNET)","volume":"25","author":"U Nowak-G\u00f6ttl","year":"1995","journal-title":"Med Pediatr Oncol"},{"issue":"04","key":"ref57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2141.1992.tb04562.x","article-title":"Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma","volume":"80","author":"T Facon","year":"1992","journal-title":"Br J Haematol"},{"issue":"06","key":"ref58","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/annonc\/mdi171","article-title":"Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis","volume":"16","author":"C C Chen","year":"2005","journal-title":"Ann Oncol"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/cren.2018.0032","article-title":"Acquired von Willebrand disease secondary to clear cell renal cell carcinoma","volume":"4","author":"B Odom","year":"2018","journal-title":"J Endourol Case Rep"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"bcr2014205248","DOI":"10.1136\/bcr-2014-205248","article-title":"Acquired von Willebrand's disease associated with epithelial myoepithelial carcinoma of the parotid salivary gland","volume":"2014","author":"G S Chilvers","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/08880010500457749","article-title":"Acquired von Willebrand syndrome in a patient with Ewing sarcoma","volume":"23","author":"M Elli","year":"2006","journal-title":"Pediatr Hematol Oncol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0140-6736(92)92434-H","article-title":"Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link?","volume":"340","author":"T E Warkentin","year":"1992","journal-title":"Lancet"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJM195807242590416","article-title":"Gastrointestinal bleeding in aortic stenosis","volume":"259","author":"E C Heyde","year":"1958","journal-title":"N Engl J Med"},{"issue":"06","key":"ref64","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/icvts\/ivu305","article-title":"Shear-stress induced acquired von Willebrand syndrome in children with congenital heart disease","volume":"19","author":"F Loeffelbein","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"03","key":"ref65","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijcard.2014.07.104","article-title":"Acquired von Willebrand syndrome in adult patients with congenital heart disease","volume":"176","author":"H C Waldow","year":"2014","journal-title":"Int J Cardiol"},{"issue":"04","key":"ref66","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5830\/CVJA-2015-093","article-title":"Acquired von Willebrand syndrome in children with aortic and pulmonary stenosis","volume":"27","author":"F K Binneto\u011flu","year":"2016","journal-title":"Cardiovasc J S Afr"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/blood.2022015699","article-title":"Perioperative diagnosis and impact of acquired von Willebrand syndrome in infants with congenital heart disease","volume":"141","author":"V Icheva","year":"2023","journal-title":"Blood"},{"issue":"04","key":"ref68","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"A Vincentelli","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"ref69","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.5551\/jat.30809","article-title":"Unexpectedly high prevalence of acquired von Willebrand syndrome in patients with severe aortic stenosis as evaluated with a novel large multimer index","volume":"22","author":"T Tamura","year":"2015","journal-title":"J Atheroscler Thromb"},{"issue":"04","key":"ref70","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jocs.12131","article-title":"Gastrointestinal bleeding and aortic stenosis (Heyde syndrome): the role of aortic valve replacement","volume":"28","author":"R A Saad","year":"2013","journal-title":"J Card Surg"},{"issue":"02","key":"ref71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jth.12780","article-title":"Remission of recurrent gastrointestinal bleeding after septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy-associated acquired von Willebrand syndrome","volume":"13","author":"J L Blackshear","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref72","doi-asserted-by":"crossref","first-page":"102431","DOI":"10.1016\/j.rpth.2024.102431","article-title":"Mitral regurgitation is associated with similar loss of von Willebrand factor large multimers but lower frequency of anemia compared with aortic stenosis","volume":"8","author":"H Takiguchi","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"ref73","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.12734","article-title":"Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation","volume":"12","author":"J L Blackshear","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref74","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/clc.23538","article-title":"Acquired von Willebrand syndrome and factor VIII in patients with moderate to severe mitral regurgitation undergoing transcatheter mitral valve repair","volume":"44","author":"C Meindl","year":"2021","journal-title":"Clin Cardiol"},{"issue":"01","key":"ref75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11239-019-01849-2","article-title":"Acquired Von Willebrand syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians","volume":"48","author":"R Mehta","year":"2019","journal-title":"J Thromb Thrombolysis"},{"issue":"02","key":"ref76","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.athoracsur.2022.11.023","article-title":"The Society of Thoracic Surgeons Intermacs 2022 Annual Report: focus on the 2018 heart transplant allocation system","volume":"115","author":"M Yuzefpolskaya","year":"2023","journal-title":"Ann Thorac Surg"},{"issue":"06","key":"ref77","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10620-015-3538-7","article-title":"Characteristics of gastrointestinal bleeding after placement of continuous-flow left ventricular assist device: a case series","volume":"60","author":"J Marsano","year":"2015","journal-title":"Dig Dis Sci"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1159894","DOI":"10.3389\/fcvm.2023.1159894","article-title":"Shear-induced acquired von Willebrand syndrome: an accomplice of bleeding events in adults on extracorporeal membrane oxygenation support","volume":"10","author":"H Wang","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"04","key":"ref79","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/ehf2.14433","article-title":"Gastrointestinal bleeding on continuous-flow left ventricular assist device therapy","volume":"10","author":"Y Hammer","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"23","key":"ref80","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.2169\/internalmedicine.52.0825","article-title":"Acquired von Willebrand syndrome associated with Hashimoto's thyroiditis and subcutaneous mucosa-associated lymphoid tissue lymphoma","volume":"52","author":"T Koyama","year":"2013","journal-title":"Intern Med"},{"key":"ref81","first-page":"208597","article-title":"Acquired Von Willebrand's syndrome in systemic lupus erythematosus","volume":"2014","author":"S Taveras Alam","year":"2014","journal-title":"Case Rep Hematol"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1528-1157.1992.tb02303.x","article-title":"Valproate therapy induces von Willebrand disease type I","volume":"33","author":"W Kreuz","year":"1992","journal-title":"Epilepsia"},{"issue":"05","key":"ref83","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MBC.0b013e3282f3f9ec","article-title":"High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study","volume":"19","author":"S Koenig","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"04","key":"ref84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2002-34499","article-title":"Pro- and anticoagulatory factors under sodium valproate-therapy in children","volume":"33","author":"M C Banerjea","year":"2002","journal-title":"Neuropediatrics"},{"issue":"01","key":"ref85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajh.2830490114","article-title":"Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor","volume":"49","author":"G Castaman","year":"1995","journal-title":"Am J Hematol"},{"issue":"02","key":"ref86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ajh.2830410218","article-title":"Acquired von Willebrand's disease, IgE polyclonal gammopathy and griseofulvin therapy","volume":"41","author":"M E Conrad","year":"1992","journal-title":"Am J Hematol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.lungcan.2021.03.021","article-title":"Squamous cell carcinoma associated with acquired von Willebrand disease due to immune checkpoint inhibitor treatment","volume":"155","author":"T Sumi","year":"2021","journal-title":"Lung Cancer"},{"issue":"02","key":"ref88","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00000658-197902000-00017","article-title":"Effect of dextran on factor VIII (antihemophilic factor) and platelet function","volume":"189","author":"M Aberg","year":"1979","journal-title":"Ann Surg"},{"issue":"11","key":"ref89","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s001340101107","article-title":"Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200\/0.5\/6) in healthy human subjects","volume":"27","author":"E de Jonge","year":"2001","journal-title":"Intensive Care Med"},{"issue":"08","key":"ref90","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJM200108233450818","article-title":"Acquired type I von Willebrand's disease associated with highly substituted hydroxyethyl starch","volume":"345","author":"A P Jonville-B\u00e9ra","year":"2001","journal-title":"N Engl J Med"},{"issue":"13","key":"ref91","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/bloodadvances.2021004957","article-title":"Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination","volume":"5","author":"A J Portuguese","year":"2021","journal-title":"Blood Adv"},{"issue":"08","key":"ref92","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","article-title":"Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches","volume":"92","author":"A B Federici","year":"1998","journal-title":"Blood"},{"issue":"01","key":"ref93","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.10074","article-title":"Acquired von Willebrand disease\u2013hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion","volume":"70","author":"R D Frank","year":"2002","journal-title":"Am J Hematol"},{"issue":"06","key":"ref94","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1111\/hae.12520","article-title":"Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand disease","volume":"20","author":"S B Patel","year":"2014","journal-title":"Haemophilia"},{"issue":"14","key":"ref95","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1182\/bloodadvances.2021004843","article-title":"Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease","volume":"5","author":"K E Dane","year":"2021","journal-title":"Blood Adv"},{"issue":"03","key":"ref96","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11239-019-02018-1","article-title":"Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience","volume":"49","author":"T Tran","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"03","key":"ref97","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2516.2001.00500.x","article-title":"High-dose DDAVP intranasal spray (stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A","volume":"7","author":"C Leissinger","year":"2001","journal-title":"Haemophilia"},{"issue":"01","key":"ref98","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-0037-1619606","article-title":"Acquired von Willebrand syndrome 2004: international registry\u2013diagnosis and management from online to bedside","volume":"24","author":"A B Federici","year":"2004","journal-title":"Hamostaseologie"},{"key":"ref99","volume-title":"PB0167 - Emicizumab use in Acquired von Willebrand Disease: Single Case Report","author":"M Escobar","year":"2022"},{"issue":"01","key":"ref100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/hae.14450","article-title":"Off-label use of emicizumab in persons with acquired haemophilia A and von Willebrand disease: a scoping review of the literature","volume":"28","author":"V M Thomas","year":"2022","journal-title":"Haemophilia"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-0044-1787662","article-title":"Emicizumab in type 3 von Willebrand disease: report of a case with an alloantibody and literature review","volume":"51","author":"A C Giuffrida","year":"2025","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.1060","article-title":"Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease","volume":"66","author":"P W Friederich","year":"2001","journal-title":"Am J Hematol"},{"issue":"03","key":"ref103","first-page":"666","article-title":"A case of acquired von Willebrand syndrome successfully treated with recombinant factor VIIa during thyroidectomy","volume":"92","author":"A Smaradottir","year":"2004","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref104","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MBC.0b013e3280100d1e","article-title":"The use of recombinant activated factor VII in congenital and acquired von Willebrand disease","volume":"17","author":"M Franchini","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"S 03","key":"ref105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/hae.14033","article-title":"Acquired bleeding disorders","volume":"27","author":"A Tiede","year":"2021","journal-title":"Haemophilia"},{"issue":"08","key":"ref106","first-page":"e28080","article-title":"Multimodal treatment and diagnostic modalities in the setting of Heyde's syndrome: a systematic review","volume":"14","author":"D Jamil","year":"2022","journal-title":"Cureus"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"879579","DOI":"10.3389\/fmed.2022.879579","article-title":"Bleeding during veno-venous ECMO: prevention and treatment","volume":"9","author":"J Kalbhenn","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"14","key":"ref108","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"J P Fermand","year":"2018","journal-title":"Blood"},{"issue":"06","key":"ref109","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/hae.14648","article-title":"Acquired von Willebrand syndrome and lymphoid neoplasms: a review of malignancy management, and propositions of practical recommendations","volume":"28","author":"C Nicol","year":"2022","journal-title":"Haemophilia"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2021.11.013","article-title":"Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: a case series from two French centers","volume":"209","author":"M Haddad","year":"2022","journal-title":"Thromb Res"},{"issue":"05","key":"ref111","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1159\/000536650","article-title":"Acquired von Willebrand syndrome associated with a smoldering multiple myeloma, successfully treated by daratumumab, lenalidomide, and dexamethasone","volume":"147","author":"M Iarossi","year":"2024","journal-title":"Acta Haematol"},{"issue":"04","key":"ref112","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11239-023-02799-6","article-title":"Acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib","volume":"55","author":"A Saldanha","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00508-022-02012-3","article-title":"Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy: breaking a dangerous bond","volume":"134","author":"G Jeryczynski","year":"2022","journal-title":"Wien Klin Wochenschr"},{"issue":"12","key":"ref114","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00277-022-04991-9","article-title":"Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy","volume":"101","author":"A Green","year":"2022","journal-title":"Ann Hematol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2022.08.025","article-title":"Acquired von Willebrand syndrome: five cases report and literature review","volume":"218","author":"I Ghariani","year":"2022","journal-title":"Thromb Res"},{"issue":"01","key":"ref116","first-page":"7","article-title":"Acquired von Willebrand's syndrome in a patient with concomitant chronic lymphocytic lymphoma and smoldering multiple myeloma","volume":"107","author":"N Haribhakti","year":"2024","journal-title":"R I Med J (2013)"},{"issue":"13","key":"ref117","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1080\/10428194.2022.2113534","article-title":"Successful and safe response to ibrutinib alone in treating relapsed Waldenstr\u00f6m macrogobulinemia and related acquired von Willebrand syndrome: an option to consider","volume":"63","author":"A Butelet","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"02","key":"ref118","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/10428194.2021.1992766","article-title":"Bortezomib provides favorable efficacy in type 3 acquired von Willebrand syndrome related to lymphoplasmacytic lymphoma\/Waldenstrom's macroglobulinemia","volume":"63","author":"D Kong","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/20406207211039326","article-title":"Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenstr\u00f6m macroglobulinemia","volume":"12","author":"M Poza","year":"2021","journal-title":"Ther Adv Hematol"},{"issue":"04","key":"ref120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2169\/internalmedicine.9815-22","article-title":"Acquired von Willebrand Syndrome in a patient with multiple comorbidities, including MALT lymphoma with IgA monoclonal gammopathy and hyperviscosity syndrome","volume":"62","author":"M Owari","year":"2023","journal-title":"Intern Med"},{"issue":"05","key":"ref121","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41375-018-0077-1","article-title":"Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet","volume":"32","author":"T Barbui","year":"2018","journal-title":"Leukemia"},{"issue":"01","key":"ref122","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12885-019-5387-9","article-title":"A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms","volume":"19","author":"T Rungjirajittranon","year":"2019","journal-title":"BMC Cancer"},{"issue":"06","key":"ref123","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-2006-949664","article-title":"The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera","volume":"32","author":"J J Michiels","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"03","key":"ref124","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bjh.18322","article-title":"Practical management of the haemorrhagic complications of myeloproliferative neoplasms","volume":"199","author":"E Jones","year":"2022","journal-title":"Br J Haematol"},{"issue":"10","key":"ref125","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","article-title":"Clinical significance of inhibitors in acquired von Willebrand syndrome","volume":"91","author":"H Mohri","year":"1998","journal-title":"Blood"},{"issue":"19","key":"ref126","first-page":"713","article-title":"[Hemostasis disorders with reduced activity of the von Willebrand factor in myeloproliferative syndromes]","volume":"113","author":"L Leupin","year":"1983","journal-title":"Schweiz Med Wochenschr"},{"issue":"01","key":"ref127","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/16078454.2021.1892322","article-title":"Differential diagnostic and treatment difficulties in a patient with acquired von Willebrand syndrome","volume":"26","author":"F Magyari","year":"2021","journal-title":"Hematology"},{"issue":"03","key":"ref128","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00277-005-0024-x","article-title":"Acquired von Willebrand syndrome type IIA in a patient with aortic valve stenosis and myeloproliferative disorder","volume":"85","author":"V Gartner","year":"2006","journal-title":"Ann Hematol"},{"issue":"02","key":"ref129","first-page":"e34905","article-title":"Heyde syndrome complicated by essential thrombocythemia: a case report","volume":"15","author":"M Imawaka","year":"2023","journal-title":"Cureus"},{"issue":"11","key":"ref130","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00277-022-04943-3","article-title":"Concealed by the convenient: acquired von Willebrand syndrome in myeloproliferative neoplasm requires a thorough evaluation","volume":"101","author":"J M Stempel","year":"2022","journal-title":"Ann Hematol"},{"issue":"05","key":"ref131","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1160\/TH10-08-0517","article-title":"Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation","volume":"105","author":"S Giannini","year":"2011","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref132","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0609.2000.90214.x","article-title":"Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies","volume":"65","author":"M Bangerter","year":"2000","journal-title":"Eur J Haematol"},{"issue":"10","key":"ref133","doi-asserted-by":"crossref","first-page":"e2442324","DOI":"10.1001\/jamanetworkopen.2024.42324","article-title":"Gastrointestinal angiodysplasia resolution after transcatheter aortic valve implantation","volume":"7","author":"L CMJ Goltstein","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"06","key":"ref134","first-page":"524","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"75","author":"A Vahanian","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"09","key":"ref135","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.jtha.2024.06.007","article-title":"Acquired von Willebrand syndrome during extracorporeal membrane oxygenation support: a comprehensive review of current evidence: communication from the ISTH SSC on perioperative and critical care thrombosis and hemostasis","volume":"22","author":"C Frere","year":"2024","journal-title":"J Thromb Haemost"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2765-9556.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:30:57Z","timestamp":1787092257000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2765-9556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":134,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2026,8,18]]},"published-print":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2765-9556","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]}}}